SEC 13F Intelligence

Knoll Capital Management, LLC / AVXL

Knoll Capital Management, LLC’s Anavex Life Sciences Corp Position

Does Knoll Capital Management, LLC own Anavex Life Sciences Corp (AVXL)? Not currently — the last reported position was 210.8K shares worth $3M in Q1 2022; the fund’s latest 13F (Q1 2026) no longer reports it.

Position Value
$3M
Q1 2022
Shares
210.8K
% of Portfolio
+1.63%
Quarters Held
10
position exited

Position History AVXL

Reported value by quarter
Q4 ’18: $1MQ4 ’18Q1 ’19: $2MQ2 ’19: $2MQ2 ’19Q3 ’19: $2MQ4 ’19: $2MQ4 ’19Q1 ’20: $2MQ2 ’20: $4MQ2 ’20Q3 ’20: $3MQ4 ’20: $4MQ4 ’20Q1 ’22: $3Mfilingsflow.com
QuarterSharesValue% of Portfolio
Q1 2022210.8K$3M+1.63%
Q4 2020670.8K$4M+2.47%
Q3 2020620.8K$3M+2.32%
Q2 2020724.2K$4M+2.09%
Q1 2020724.2K$2M+2.14%
Q4 2019724.2K$2M+1.39%
Q3 2019724.2K$2M+2.09%
Q2 2019724.2K$2M+2.00%
Q1 2019724.2K$2M+1.68%
Q4 2018724.2K$1M+1.29%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Knoll Capital Management, LLC’s full portfolio or all institutional holders of AVXL.